Because these drugs can affect how treatment is tolerated and how well it works, your care team will weigh the potential risks and benefits before deciding whether to pause or continue a GLP-1 during cancer treatment
What Most Patients Want to Know These are some of the most common questions patients ask before beginning treatment or moving to a new prescribed dose
IV amino-hexanoic, amino-pentanoic or amino butyric acid
Ingredients Water, Ethylhexyl Palmitate, Glycereth-26, Glycerin, Cetearyl Alcohol, Niacinamide, Hydrogenated Poly(C6-14 Olefin), Beeswax, Caprylic/Capric Triglyceride, Polyglyceryl-2 Stearate, Dipropylene Glycol, Isododecane, Glyceryl Stearate, Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Stearyl Alcohol, Glycol Stearate SE, Sodium Polyacrylate, Hydroxyacetophenone, Stearic Acid, Dimethiconol, Dimethicone/Vinyl dimethicone crosspolymer, Hydrogenated Polydecene, Hydrogenated Lecithin, Tranexamic Acid, Betaine, Glutathione, Panthenol, Fragrance, Hippophae Rhamnoides Fruit Oil, Butylene Glycol, Adenosine, Sorbitan Isostearate, Caprylyl Glycol, Trideceth-6, 1,2-Hexanediol, Disodium EDTA, Sodium Hyaluronate, Ascorbic Acid
I tried my sick day logic (read the sick day management protocol here )reduce by 2-4 units and ended up with severe hypos all day (read our hypo guide here )